The Study
Tell Me What Your Blood β-Carotene Level Is, I Will Tell You What Your Health Risk Is! The Viewpoint of the SUVIMAX Researchers
This study noticed that men who took antioxidant pills seemed to get less cancer, but it didn’t test it like a science experiment—it just watched what happened. So we can’t say the pills caused the difference, only that they might be connected.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
A long study gave people low-dose vitamin pills for 7.5 years and saw what happened to their cancer rates.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 524 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1The difference suggests antioxidant supplements might help men more, possibly because men started with lower vitamin levels.
- 2Men who took the pills had less cancer and fewer cancer deaths; women did not.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Annals of Nutrition and Metabolism
Year
2009
Authors
S. Hercberg, S. Czernichow, P. Galan
Related Content
Claims (2)
Men who took low-dose antioxidant supplements for seven and a half years had lower rates of cancer and cancer-related death compared to those who did not, while women taking the same supplements showed no such reduction.
Men have lower baseline levels of beta-carotene than women, and this difference is associated with different cancer outcomes after antioxidant supplementation.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.